Journal
THORAX
Volume 77, Issue 11, Pages 1059-1069Publisher
BMJ PUBLISHING GROUP
DOI: 10.1136/thorax-2022-219016
Keywords
asthma; paediatric asthma
Categories
Funding
- National Institutes of Health (Bethesda, MD) [U01 AI-087881, R01 AI-114552, R01 AI-108588, R01 AI-134940, UG3/UH3 OD-023253]
Ask authors/readers for more resources
This multicentre prospective cohort study integrated clinical, virus and lipidomics data to identify different endotypes of bronchiolitis and examined their relationship with subsequent asthma risk.
Background Bronchiolitis is the leading cause of hospitalisation of US infants and an important risk factor for childhood asthma. Recent evidence suggests that bronchiolitis is clinically heterogeneous. We sought to derive bronchiolitis endotypes by integrating clinical, virus and lipidomics data and to examine their relationship with subsequent asthma risk. Methods This is a multicentre prospective cohort study of infants (age <12 months) hospitalised for bronchiolitis. We identified endotypes by applying clustering approaches to clinical, virus and nasopharyngeal airway lipidomic data measured at hospitalisation. We then determined their longitudinal association with the risk for developing asthma by age 6 years by fitting a mixed-effects logistic regression model. To account for multiple comparisons of the lipidomics data, we computed the false discovery rate (FDR). To understand the underlying biological mechanism of the endotypes, we also applied pathway analyses to the lipidomics data. Results Of 917 infants with bronchiolitis (median age, 3 months), we identified clinically and biologically meaningful lipidomic endotypes: (A) cinical(classic)lipid(mixed) (n=263), (B) clinical(severe)lipid(sphingolipids-high) (n=281), (C) clinical(moderate)lipid(phospholipids-high) (n=212) and (D) clinical(atopic)lipid(sphingolipids-low) (n=161). Endotype A infants were characterised by 'classic' clinical presentation of bronchiolitis. Profile D infants were characterised by a higher proportion of parental asthma, IgE sensitisation and rhinovirus infection and low sphingolipids (eg, sphingomyelins, ceramides). Compared with endotype A, profile D infants had a significantly higher risk of asthma (22% vs 50%; unadjusted OR, 3.60; 95% CI 2.31 to 5.62; p<0.001). Additionally, endotype D had a significantly lower abundance of polyunsaturated fatty acids (eg, docosahexaenoic acid; FDR=0.01). The pathway analysis revealed that sphingolipid metabolism pathway was differentially expressed in endotype D (FDR=0.048). Conclusions In this multicentre prospective cohort study of infants with bronchiolitis, integrated clustering of clinical, virus and lipidomic data identified clinically and biologically distinct endotypes that have a significantly differential risk for developing asthma.Delete
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available